68倍PE,凯赛生物值不值?

钛媒体APP
Jul 26

文 | 节点财经,作者 | 八真引央企招商局入股,牵手新能源产业巨擘宁德时代,被誉为“合成生物第一股”的凯赛生物近年来风头正盛。体现在资本市场,截至7月25日收盘,凯赛生物(688065.SH)市值约353亿元,位于化学制品第五位,仅次于万华化学、巨化股份、卫星化学和合盛硅业。但若论估值,凯赛生物动态市盈率(PE)接近68倍,遥遥领先万华化学约16倍,巨化股份约22倍,卫星化学将将10倍,也优于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10